Liquid biopsy in the diagnosis of primary brain tumors Journal Article


Authors: Bale, T. A.; Mellinghoff, I. K.; Graham, M. S.
Article Title: Liquid biopsy in the diagnosis of primary brain tumors
Abstract: The diagnosis of primary brain tumors at presentation and with progression presents unique challenges, in part due to the inherent risks and limitations of neurosurgical sampling. Emerging liquid biopsy techniques analyzing circulating tumor DNA (ctDNA) in the cerebrospinal fluid (CSF) are potentially revolutionary, affording a minimally invasive means of collecting valuable tumor-related information. Here we review the most salient factors contributing to successful detection of CSF ctDNA, the most developed ctDNA assay techniques and the clinical contexts in which CSF liquid biopsy has been applied. Future opportunities for liquid biopsy advancement are also explored. Integration of these techniques into routine clinical care will require rigorous validation through clinical trials and standardization of assay pipelines but holds great promise for the future of neuro-oncology. © 2025
Keywords: brain tumor; cerebrospinal fluid; circulating tumor dna; liquid biopsy
Journal Title: Advances in Cancer Research
Volume: 166
ISSN: 0065-230X
Publisher: Academic Press, Elsevier Inc  
Publication status: Published
Date Published: 2025-01-01
Start Page: 81
End Page: 102
Language: English
DOI: 10.1016/bs.acr.2025.05.004
PROVIDER: scopus
PUBMED: 40675690
DOI/URL:
Notes: This is a chapter published under the book "Primary Brain Tumors in Adults: Advances in Mechanistic Understanding, Evaluation, and Management" (ISBN: 978-0-443-34479-4) -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maya Srikanth Graham
    24 Graham
  2. Tejus Bale
    130 Bale